PUBLISHER: The Business Research Company | PRODUCT CODE: 1751072
PUBLISHER: The Business Research Company | PRODUCT CODE: 1751072
Pharmaceutical stability and storage services are specialized offerings designed to ensure that pharmaceutical products, including drugs, medications, and vaccines, retain their quality, efficacy, and safety throughout their shelf life. These services involve maintaining controlled storage environments, conducting stability studies to monitor chemical, physical, and microbiological changes, and ensuring compliance with regulatory standards.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The primary pharmaceutical stability and storage services include stability testing and storage solutions. Stability services evaluate how pharmaceutical products maintain their quality, potency, and safety under varying environmental conditions over time. These services apply to various products such as tablets, capsules, injectable solutions, oral suspensions, combination products, and others, and can involve both small and large molecules. Stability and storage services are provided through in-house and outsourcing models, and are utilized by biopharmaceutical companies, contract manufacturing organizations, contract research organizations, and other entities.
The pharmaceutical stability and storage services market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical stability and storage services market statistics, including pharmaceutical stability and storage services industry global market size, regional shares, competitors with a pharmaceutical stability and storage services market share, detailed pharmaceutical stability and storage services market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical stability and storage services industry. This pharmaceutical stability and storage services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pharmaceutical stability and storage services market size has grown strongly in recent years. It will grow from $2.66 billion in 2024 to $2.84 billion in 2025 at a compound annual growth rate (CAGR) of 6.7%. The growth observed during the historic period can be attributed to the rising demand for biologics, the increasing prevalence of chronic diseases, growth in drug development, the growing complexity of drug formulations, and heightened research and development efforts within the pharmaceutical industry.
The pharmaceutical stability and storage services market size is expected to see strong growth in the next few years. It will grow to $3.65 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth projected during the forecast period can be attributed to the rise of personalized medicine, the expansion of cold chain logistics, a growing biopharma pipeline, increasing biologic drug approvals, and a higher demand for stability testing. Key trends during this period include technological advancements, progress in cryogenic storage technologies, developments in digital monitoring technologies, innovations in packaging technologies, and the advancement of temperature-controlled storage systems.
The growing number of novel drug approvals is expected to drive the expansion of the pharmaceutical stability and storage services market in the future. A novel drug is a newly developed pharmaceutical compound that has not been previously approved for use or marketed. The surge in novel drug approvals is largely attributed to advancements in biotechnology, which have enabled the discovery of new compounds, as well as improvements in regulatory processes that facilitate faster and more efficient drug development. The increase in novel drug approvals boosts the demand for pharmaceutical stability and storage services, which ensure the proper conditions, compliance, and extended shelf-life management of these products. For example, in October 2023, the U.S. Food and Drug Administration (FDA) reported that 37 novel drugs were approved in 2022, followed by 50 in 2024, advancing treatments in areas such as cancer, rare diseases, neurology, infections, and conditions such as schizophrenia, pain, and Alzheimer's. As such, the rising number of novel drug approvals is fueling the growth of the pharmaceutical stability and storage services market.
Leading companies in the pharmaceutical stability and storage services market are focusing on the development of technologically advanced solutions, such as cryogenic storage suites, to improve the preservation of temperature-sensitive pharmaceutical products. Cryogenic storage suites are specialized facilities that maintain extremely low temperatures, typically below -150°C, to preserve temperature-sensitive biological and pharmaceutical materials such as cell therapies, vaccines, and biologics. For instance, in December 2024, Astoriom, a UK-based stability and biospecimen storage company, unveiled a cryogenic storage suite at its Tramore facility in County Waterford, Ireland. This expansion significantly enhances its capacity to store biological samples, offering precise temperature control down to -196°C, large storage capacity, ISO 9001 certification for regulatory compliance, and advanced security features, such as access controls and monitoring systems, to ensure safe long-term preservation.
In June 2022, Cambrex Corporation, a US-based contract development and manufacturing organization, acquired Q1 Scientific for an undisclosed amount. This acquisition allows Cambrex to expand its presence in Europe, bolster its stability storage service capabilities, and strengthen its portfolio of outsourced pharmaceutical solutions to meet the growing demands of the industry. Q1 Scientific Limited, based in Ireland, specializes in providing pharmaceutical stability and storage services.
Major players in the pharmaceutical stability and storage services market are Cencora Inc, SGS S.A., Eurofins Scientific SE, Catalent Inc, Charles River Laboratories, Intertek Group plc, Element Materials Technology Inc, Alloga UK Ltd., ALS Limited, Pharmaceutical Contract Industries Pharma Services., Almac Group, Alcami Corporation, BioLife Solutions Inc., Auriga Research Private Limited, Reading Scientific Services Ltd., Lucideon Limited, Q Laboratories Inc, PD Partners, Precision Stability Storage, Roylance Stability Storage Limited.
North America was the largest region in the pharmaceutical stability and storage services market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharmaceutical stability and storage services report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the pharmaceutical stability and storage services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The pharmaceutical stability and storage services market consists of revenues earned by entities by providing services such as photostability testing, cold chain management, disaster recovery and backup storage. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmaceutical stability and storage services market also includes sales of stability chambers, cryogenic storage systems, cold storage units and automated sample management systems. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pharmaceutical Stability And Storage Services Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on pharmaceutical stability and storage services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for pharmaceutical stability and storage services ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The pharmaceutical stability and storage services market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.